Cytology Reflex to Cell Block and Relevant IHC – Body Fluid
Test Purpose: Cytological examination of body fluid with reflex preparation of a cell block and application of relevant immunohistochemistry (IHC) markers when required to characterize atypical/suspicious cells and determine their origin.
Specimen:
Pleural fluid
Peritoneal/ascitic fluid
Pericardial fluid
Other body fluids, as clinically indicated
Methodology:
Cytospin/conventional cytology examination
Cell block preparation when indicated
H&E staining
Reflex IHC based on cytomorphology and clinical suspicion
Clinical Indications:
Suspected malignant cells in body fluid
Evaluation of metastatic carcinoma
Differentiation of carcinoma, lymphoma, melanoma and reactive mesothelial cells
Determination of the likely primary site in metastatic malignancy
Further characterization of an atypical or indeterminate cell population
IHC Markers: Markers are selected according to the morphology and clinical context. Depending on the case, panels may include pan-cytokeratin, CK7, CK20, BerEP4, MOC31, calretinin, WT1, D2-40, GATA3, TTF-1, Napsin A, PAX8, ER, PR, CDX2, SATB2, PSA, NKX3.1, SOX10/S100, and lymphoid markers such as CD45, among others.
Report Includes:
Cytological interpretation
Cell block adequacy
Presence/absence of malignant cells
IHC findings, when performed
Integrated interpretation with likely cell/tumor origin, where possible
Turnaround Time: Typically 2–5 working days, depending on the number and complexity of IHC markers required.
Note: Reflex IHC is performed selectively based on cytological findings and may require additional specimen or testing if cellularity is insufficient.